风险沟通概要

[1] risk communication. http://www.center for risk communication.com . 2006

[2] Risk Communication in Clinical Consultation. Thomson R. Clinical Medicine . 2005

[3] Drug-Safety Data:Too Much Information. Wang S S. The Wall Street Journal . 2008

[4] Is this clinical trial fully registered-A statement from the inter-national committee of medical journal editors. http://www.icmje.org/clin_trialup.htm . 2005

[5] FDA Guidance for Industry:Information Program on Clin-ical Trials for Serious or Life Threatening Diseases and Cond-itions. FDA. . 2004

[6] The Art and Science of Risk Management. Bush J. Drug Safety . 2005

[7] Risk Analysis, Perception and Management. . 1992

[8] Guidance:Drug Safety In-formation-FDA‘s Communication to the Public. US Food and Drug Administration. . 2007

[1] risk communication. http://www.center for risk communication.com . 2006

[2] Risk Communication in Clinical Consultation. Thomson R. Clinical Medicine . 2005

[3] Drug-Safety Data:Too Much Information. Wang S S. The Wall Street Journal . 2008

[4] Is this clinical trial fully registered-A statement from the inter-national committee of medical journal editors. http://www.icmje.org/clin_trialup.htm . 2005

[5] FDA Guidance for Industry:Information Program on Clin-ical Trials for Serious or Life Threatening Diseases and Cond-itions. FDA. . 2004

[6] The Art and Science of Risk Management. Bush J. Drug Safety . 2005

[7] Risk Analysis, Perception and Management. . 1992

[8] Guidance:Drug Safety In-formation-FDA‘s Communication to the Public. US Food and Drug Administration. . 2007